Skip to main content
. 2020 Sep 14;20:233. doi: 10.1186/s12871-020-01111-w

Table 3.

Adverse outcomes

TIVA INHA P Value
N (%) N (%)
Dichotomous Outcomes
 30-day Mortality 4 (2.1) 11 (4.7) 0.106
 MACE 4 (2.1) 11 (4.7) 0.106
 MOD 6 (3.3) 9 (3.9) 0.797
 Blood Transfusion 80 (43.5) 78 (33.5) 0.189
Median (IQR) Median (IQR)
Continuous Outcomes
 Blood Loss 400 (245,800) 400 (300,800) 0.301
 Length of Stay (days) 15 (13,20) 16 (13,20) 0.920

IQR Interquartile range, MACE Major adverse cardiac events, MOF Multiple organ failure, RR Risk ratio